Neurocrine Biosciences (NBIX) Goodwill (2022 - 2024)

Neurocrine Biosciences has reported Goodwill for 3 years, with the latest figure at $5.7 million in Q4 2024.

• For the quarter ending Q4 2024, Goodwill fell 1.72% year-over-year to $5.7 million; the trailing twelve-month figure through Dec 2024 stood at $5.7 million (down 1.72% YoY), and the FY2024 full-year result was $5.7 million, down 1.72% from the prior year.
• Goodwill for Q4 2024 stood at $5.7 million, down from $6.1 million in the prior quarter.
• The five-year high for Goodwill was $6.1 million in Q3 2024, with the low at $5.4 million in Q4 2022.
• Historically, Goodwill has averaged $5.7 million across 3 years, with a median of $5.7 million in 2023.
• The largest YoY upside for Goodwill was 10.91% in 2024 against a maximum downside of 1.72% in 2024.
• Neurocrine Biosciences' Goodwill stood at $5.4 million in 2022, then rose by 7.41% to $5.8 million in 2023, then declined by 1.72% to $5.7 million in 2024.
• The last three Goodwill figures came in at $5.7 million (Q4 2024), $6.1 million (Q3 2024), and $5.7 million (Q2 2024), per Business Quant data.